Ting Rao
Jiefang Road 238
Wuhan, 430060, China
Wuhan, 430060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Computed tomography-ultrasonography (US) fusion for percutaneous nephrolithotomy access versus conventional US: A multicentre randomised trial.
Journal: BJU international
Published: May 23, 2026
Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway.
Journal: Translational oncology
Published: February 17, 2026
Hyaluronic acid-coated Cu/Mn Prussian blue nanocubes amplify cuproptosis and cGAS-STING signaling for synergistic prostate cancer therapy.
Journal: International journal of biological macromolecules
Published: January 19, 2026
BMAL1 regulates tubular epithelial-derived exosomal miR-27a-3p to inhibit macrophage-myofibroblast transition and alleviate ischemia/reperfusion-induced renal fibrosis.
Journal: Theranostics
Published: October 29, 2025
CREB1/CRTC2 regulated tubular epithelial-derived exosomal miR-93-3p promotes kidney injury induced by calcium oxalate via activating M1 polarization and macrophage extracellular trap formation.
Journal: Journal of nanobiotechnology
Published: December 10, 2024
GOLPH3 promotes calcium oxalate-induced renal injury and fibrosis through Golgi stress-mediated apoptosis and inflammatory responses.
Journal: Scientific reports
Published: November 12, 2024
UHRF1 promotes calcium oxalate-induced renal fibrosis by renal lipid deposition via bridging AMPK dephosphorylation.
Journal: Cell biology and toxicology
Published: September 12, 2024
The bach1/G9a/Slc7a11 axis epigenetically promotes renal fibrosis by mediated ferroptosis.
Journal: International immunopharmacology
Published: June 07, 2024
The identification of key molecules and pathways in the crosstalk of calcium oxalate-treated TCMK-1 cells and macrophage via exosomes.
Journal: Scientific reports
Published: May 17, 2024
AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.
Journal: Journal of translational medicine
Published: December 04, 2023
Last Updated: 09/26/2026